Who Will Be the Google of Genomics?
The first company to offer whole genome sequencing for free can build the most valuable advertising engine in the world. by Andrew Hessel
New Trick in DNA Editing Could Safely Unlock Thousands of Cures
A CRISPR startup rewrites tiny mutations instead of cutting and pasting entire genes.
The Clock is Ticking Faster for a Patient Turned Medical Disruptor
Investors and families are counting on Onno Faber to galvanize research into neglected conditions—like the one threatening his hearing and sight.
Our Genetic Legacy
I am not afraid of the prospect of editing human genes. If we do it thoughtfully, it can be a gift to future generations.
Will You Eat CRISPR Produce?
Gene editing will make plants hardier and healthier. Hopefully people won’t freak out.
Is the World Ready for Synthetic People?
Stanford bioengineer Drew Endy doesn’t mind bringing dragons to life. What really scares him are humans. by David Ewing Duncan
Get Ready for Same-Sex Reproduction
When artificial sperm and eggs become a reality, the sex of your babymaking partner won't matter.
The Language of DNA Should Rewrite English, Too
Jargon from the pre-genomics era blinds us to new possibilities.
Blockchains Won’t Fix the Problem with Genomics
If you’ve been waiting to get your genome sequenced, will a virtual token really make you change your mind?
The Human Operating System Gets an Overhaul
Forget editing genes. This guy wants to write brand-new ones. by Steven Kotler
Power to the Patients
Racing against his own genetic disorder, Onno Faber is giving people with rare diseases the tools to make medicine work for them.